Follow the 제이시스메디칼 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 제이시스메디칼 has logged 109 reports. The latest transaction was filed on 25 October 2024 (Purchase). Among the most active insiders: 선혜진. The full history is openly available.
109
Insider Decl.
n/a
Thresholds
n/a
35 ops.
Buy Volume
n/a
20 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
제이시스메디칼 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of innovative medical devices.